𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Type I and III collagen degradation products in serum predict patient survival in head and neck squamous cell carcinoma

✍ Scribed by Sini Nurmenniemi; Marja-Kaisa Koivula; Pia Nyberg; Taina Tervahartiala; Timo Sorsa; Petri S. Mattila; Tuula Salo; Juha Risteli

Book ID
113834111
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
437 KB
Volume
48
Category
Article
ISSN
1368-8375

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Using TNM staging to predict survival in
Using TNM staging to predict survival in patients with squamous cell carcinoma of head & neck
✍ Stephen F. Hall; Patti A. Groome; Deanna Rothwell; Peter F. Dixon πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 95 KB πŸ‘ 3 views

## Background: There is a need for a classification system for prognosis based on the tnm system for patients with squamous cell carcinoma of the head and neck such that patient groupings are homogeneous within and heterogeneous between. ## Methods: Six hundred fifty-five consecutive patients wit

Survival in patients with recurrent squa
Survival in patients with recurrent squamous cell head and neck carcinoma treated with bio-chemotherapy
✍ Mario Airoldi; Antonella De Stefani; Sara Marchionatti; Fulvia Pedani; Pietro Ga πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 94 KB πŸ‘ 2 views

## Abstract ## Background We have shown that rIL‐2 administration in recurrent head and neck cancers induces a tumor‐specific T‐lymphocyte reactivity and tumor regression; in a pilot study we have shown a safe and effective administration of rIL2 after cisplatin + 5‐fluorouracil. Long‐term results